Tumor suppressor DRD2 promotes M1 polarization of macrophages and inhibits NF-κB signaling pathway to trigger breast cancer apoptosis, providing a new predictive and therapeutic target for breast cancer [42]. This evidence concerns the gene NFKB1 and breast carcinoma.